Browsing by Subject Parkinson's disease

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 27 to 46 of 57 < previous   next >
Issue DateTitleAuthor(s)
2010-07Il-Musbieħ : Malta Nursing and Midwifery Journal : Issue 47 : July 2010Cini, Louise; Malta Union of Midwives and Nurses
2004-11Il-Ħajja f'Għawdex : volume 863 : 2004Catholic Church. Diocese of Gozo (Malta)
2019Improving the quality of life for both the person with Parkinson’s and the caregiver : the contribution of movement as an artistic and expressive mediumMuschamp, Natalie
2013In vivo microdialysis to study striatal dopaminergic neurodegenerationDi Giovanni, Giuseppe; Pierucci, Massimo; Pessia, Mauro; Di Matteo, Vincenzo
2007Inflammation in Parkinson’s disease : therapeutic implicationsBenigno, Arcangelo; Esposito, Ennio; Crescimanno, Giuseppe; Matteo, Vincenzo di; Di Giovanni, Giuseppe
2013Intracerebral human microdialysis in Parkinson’s diseaseGalati, Salvatore; Di Giovanni, Giuseppe
2009Involvement of nitric oxide in nigrostriatal dopaminergic system degeneration : a neurochemical studyDi Matteo, Vincenzo; Pierucci, Massimo; Benigno, Arcangelo; Crescimanno, Giuseppe; Esposito, Ennio; Di Giovanni, Giuseppe
2007Involvement of nitric oxide in the nigrostriatal dopaminergic system degeneration : a study on the 6-OHDA model of Parkinson's diseaseBenigno, Arcangelo; Di Matteo, Vincenzo; Pierucci, Massimo; Crescimanno, Giuseppe; Esposito, Ennio; Licciardi, A.; Di Giovanni, Giuseppe
2014Licensing of generic medicines : are there any challenges left? A pharmaceutical regulatory perspectiveBorg, John Joseph; Tomasi, Paolo; Pani, Luca; Aislaitner, George; Pirozynski, Michal; Leufkens, Hubert; Melchiorri, Daniela
2018Mechanisms of action underlying the efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease : central role of disease severityStefani, Alessandro; Cerroni, Rocco; Mazzone, Paolo; Liguori, Claudio; Di Giovanni, Giuseppe; Pierantozzi, Mariangela; Galati, Salvatore
2014Monoamine modulation of tonic GABAA inhibitionCrunelli, Vincenzo; Di Giovanni, Giuseppe
2014Noradrenergic terminals regulate l-DOPA-derived dopamine extracellular levels in a region-dependent manner in Parkinsonian ratsNavailles, Sylvia; Milan, Lea; Khalki, Hanane; Di Giovanni, Giuseppe; Lagiere, Melanie; De Deurwaerdère, Philippe
2015A novel mutation in LRRK2 influences risk for Parkinson disease in the Maltese populationCamilleri, G.; Bezzina Wettinger, Stephanie; Farrugia, Rosienne; Camilleri, Simon
2021Nutraceuticals for Parkinson’s diseaseChauhdary, Zunera; Ajmal Shah, Muhammad; Saleem, Uzma; Rasul, Akhtar; Khan, Ajmal; Al-Harrasi, Ahmed; Blundell, Renald; Parambi, Della Grace Thomas; Saad Alharbi, Khalid; Shokoohinia, Yalda
1999Pitfalls in diagnosis and treatment of ParkinsonismTareki, Mahmoud Khalifa (1999)
2012Polyphenolic compounds are novel protective agents against lipid membrane damage by alpha-synuclein aggregates in vitroCaruana Grech Perry, Mario; Neuner, Johanna; Hogen, Tobias; Schmidt, Felix; Famp, Frits; Scerri, Charles; Giese, Armin; Vassallo, Neville
2016-07-26Potential role of caffeine in the treatment of Parkinson’s diseaseRoshan, Mohsin H.K.; Tambo, Amos; Pace, Nikolai Paul
2011The potential role of dietary polyphenols in Parkinson’s diseaseCaruana Grech Perry, Mario; Vassallo, Neville
2009Preferential modulation of the GABAergic vs. dopaminergic function in the substantia nigra by 5-HT2C receptorDi Giovanni, Giuseppe; Di Matteo, Vincenzo; Pierucci, Massimo; Esposito, Ennio
2017The probe : programs 1-17Chambers, Monique